Home > Neurology > Roche warns multiple sclerosis drug development hit by Ukraine war

Roche warns multiple sclerosis drug development hit by Ukraine war


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Reuters - 25/04/2022 - Roche has warned that Russia's attack on Ukraine is disrupting the development of a new generation of multiple sclerosis (MS) drugs as the industry has come to disproportionately rely on Eastern Europe for clinical trials. The pharmaceutical industry has been scrambling to find ways to keep patients in Ukraine enrolled in various clinical trials as millions have fled the war and sought shelter in neighbouring countries. "Both Ukraine and Russia historically have been very important contributors to clinical trials for patients with neurological disorders such as multiple sclerosis," the head of Roche's pharmaceutical division, Bill Anderson, told reporters on a call after the release of first-quarter sales. About 20% to 30% of patients in the global fenebrutinib MS trial programme have been from Ukraine and Russia, far above the countries' revenue potential, the Swiss company said. It said it was opening sites in additional countr...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on